US$ 29.91
is tirzepatide safer than semaglutide vs. Semaglutide: What You Should Know title ๐ Tirzepatide vs. Semaglutide:
Description
When FDA-approved (expected 2027-2028), the commercial list price is projected at $1,000-1,500/month, though manufacturer savings programs may reduce out-of-pocket costs to $25-50/month for insured patients
Yes, WiseRX often provides better discounts than insurance copays

Jarade C, Zolotarova T, Moiz A, Eisenberg MJ

"They didn't give me a choice," he says

If you or a loved one has experienced any of these gastrointestinal complications after the use of diabetes drugs, our dedicated legal team at Lundy LLP is ready to help

doi: 10.1016/j.cub.2024.02.074